CAH · News · 20260806N

Competition and Market Share

CARDINAL HEALTH INC · 2026-08-06 · Importance 17 · Surprise 24

Cardinal Health, McKesson, and Cencora collectively control more than 90% of the U.S. drug distribution market, indicating a highly concentrated domestic wholesaling structure. Cencora’s specialty assets are reportedly performing strongly and helping offset industry headwinds. McKesson is also benefiting from specialty pharmaceuticals, oncology services, and prescription-volume growth, reinforcing specialty distribution as a key competitive battleground.

Key facts

• Cardinal Health stock reached an all-time high of $243.71 and was up 55.94% over the past year. source
• Cardinal Health's Chief Information Officer Michelle D. Greene was awarded 17,230 performance share units that are set to settle on August 15, 2026 and following the award Greene directly holds 29,460 common shares. source
• Cardinal Health awarded Chief Financial Officer Aaron E. Alt 58,738 performance share units that will settle on August 15, 2026; the award was granted on August 4, 2026 at a price of $0.0000 per share and after the award Alt directly holds 85,146 common shares. source
• Mary C. Scherer reported the acquisition of 2,610 common shares on August 4, 2026 via the vesting of performance share units and the filing was made on August 6, 2026. source
• McKesson, Cardinal Health, and Cencora form an oligopoly controlling over 90% of the U.S. drug distribution market. source